Skip to main content
. 2022 Jun 8;9:924958. doi: 10.3389/fcvm.2022.924958

FIGURE 4.

FIGURE 4

Cumulative incidence function of bioprosthetic valve failure (A,C) and hemodynamic valve deterioration (B,D) accounting for death as competing risk; p values are obtained with the Gray’s test and refer to the comparison between IA ≤ 23 mm vs. IA > 23 mm (A,B) and IA > 23 mm vs. SA group (C,D). BVF, bioprosthetic valve failure; HVD, hemodynamic valve deterioration; IA, intra-annular; SA, supra-annular; TAVR, transcatheter aortic valve replacement.

HHS Vulnerability Disclosure